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 Background— Although a significant progress has been made in the management of ischemic heart disease, the 
number of severe ischemic heart disease patients is increasing.  Thus, it is crucial to develop new, non-invasive 
therapeutic strategies.  Recently, the low-intensity pulsed ultrasound (LIPUS) is used as non-invasive medical therapies 
for fracture and bone healing. Although the mechanical stimuli with acoustic pressure waves have been reported to 
induce angiogenesis, its clinical application to chronic myocardial ischemia remains unknown.  In the present study, I 
aimed to develop LIPUS therapy for the treatment of ischemic heart disease. 
Methods and Results— I first measured acoustic pressure of LIPUS by using a needle hydrophone. When increasing 
cycle number to 1, 16, 32 and 64 at the intensity of 166~193 mW/cm2 (SPTA), peak negative-pressure generated by a 1.8 
MHz transducer was decreased to 1.59, 0.77, 0.56, 0.43, and 0.36 MPa, respectively. Under those conditions, I confirmed 
that in cultured human endothelial cells, LIPUS significantly up-regulated mRNA expression of vascular endothelial 
growth factor (VEGF) with a peak at 32-cycle (P<0.05).  I then examined the in vivo effects of LIPUS in a porcine 
model of chronic myocardial ischemia with an ameroid constrictor placed around the left circumflex coronary artery 
(LCX) (n=28).  The heart was treated with either sham (n=14) or LIPUS (32-cycle with 193 mW/cm2 for 20 min, n=14) 
at 3 different short axis levels.  Four weeks after the treatment, reduced left ventricular ejection fraction (LVEF) was 
significantly improved in the LIPUS group (46±4 to 57±5%, P<0.05) without any adverse effects, whereas it remained 
unchanged in the control group (46±5 to 47±6%, P=0.33).  Capillary density in the ischemic region was significantly 
increased in the LIPUS group compared with the control group (1084±175 vs. 858±151 /mm2, P<0.05).  Regional 
myocardial blood flow (RMBF) was also significantly improved in the LIPUS group (0.78±0.2 to 1.39±0.4 ml/min/g, 
P<0.05), but not in the control group (0.84±0.3 to 0.97±0.4 ml/min/g).  Western blot analysis showed that VEGF, 
endothelial nitric oxide synthase (eNOS), and basic fibroblast growth factor (bFGF) were all significantly up-regulated 
only in the LIPUS group.  There were no adverse effects of the LIPUS therapy, such as myocardial injury and/or 
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arrhythmias. 
Conclusions— In this study, I was able to demonstrate that noninvasive LIPUS therapy effectively increased capillary 
density and RMBF and normalized ischemia-induced myocardial dysfunction without any adverse effects.  Thus, these 
results suggest that the LIPUS therapy is promising as a new, non-invasive therapy for ischemic heart disase. 
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